SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
- Sort by:
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
91
|
CROI Program Committee Chair Welcome to Tuesday
Nicolas Chomont
Université de Montréal, Montreal, Canada
HIV Assembly, Maturation Inhibitors, and Drug Resistance (ABSTRACT
27)
Eric O. Freed
National Cancer Institute, Frederick, MD, USA
Stuart J.D. Neil
King's College London, London, United Kingdom
Accelerating Tuberculosis Elimination: Short-Course Prevention and Treatment (ABSTRACT
28)
Vidya Mave
Byramjee Jeejeebhoy Government Medical College - Johns Hopkins > Research Program, Pune, India
Constance A. Benson
University of California San Diego, La Jolla, CA, USA
Treatment of Prehypertension in People Living With HIV: A Randomized Controlled Trial (ABSTRACT
148)
Lily D. Yan
Weill Cornell Medicine, New York, NY, USA
A Nurse-Led Strategy Improves Blood Pressure and Cholesterol in People With HIV: The EXTRA-CVD Trial (ABSTRACT
149)
Chris T. Longenecker
University of Washington, Seattle, WA, USA
Community Health Worker-Facilitated Telehealth for Severe Hypertension Care in Kenya and Uganda (ABSTRACT
150)
Matt Hickey
University of California San Francisco, San Francisco, CA, USA
Pitavastatin Reduces Non-Calcified Plaque via Pro-Collagen PCOLCE Independently of LDL in REPRIEVE (ABSTRACT
151)
Márton Kolossváry
Massachusetts General Hospital
QUESTIONS AND ANSWERS (Part 1)
Pitavastatin Has No Effect on Long-Term, Objective Physical Function in REPRIEVE (ABSTRACT
152)
Kristine M. Erlandson
University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Lung Function, HIV and Mortality: Analyses From the AIDS Linked to the Intravenous Experience Cohort (ABSTRACT
153)
Sarath Raju
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
Prostate Cancer Characteristics and Outcomes for Veterans With HIV in the Antiretroviral Era (ABSTRACT
154)
Keith Sigel
Icahn School of Medicine at Mt Sinai, New York, NY, USA
InSTI Switch During Menopause Is Associated With Accelerated Body Composition Change (ABSTRACT
155)
Rebecca Abelman
University of California San Francisco, San Francisco, CA, USA
QUESTIONS AND ANSWERS (Part 2)
Simultaneous Initiation in ART-Naive PWH of DTG-Based ART & 3HP Maintains Efficacious DTG Levels (ABSTRACT
156)
Ethel D. Weld
The Johns Hopkins University, Baltimore, MD, USA
Early Bactericidal Activity of the Alpibectir-Ethionamide (AlpE) Combination Against Tuberculosis (ABSTRACT
157)
Jeantelle Du Preez
TASK Applied Science, Cape Town, South Africa
NAFLD and Advanced Fibrosis Are Common in Adults With HIV and Associated With Unique Histology (ABSTRACT
158)
Jennifer C. Price
University of California San Francisco, San Francisco, CA, USA
Semaglutide Reduces Metabolic-Associated Steatotic Liver Disease in People With HIV: The SLIM LIVER (ABSTRACT
159)
Jordan E. Lake
University of Texas at Houston, Houston, TX, USA
QUESTIONS AND ANSWERS (Part 1)
Trends in HIV and HCV Prevention Efforts and Incidence Among People Who Inject Drugs in Baltimore (ABSTRACT
160)
Eshan U. Patel
The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Preclinical Pharmacokinetic Assessment of a Hepatitis C Virus Long-Acting Injectable Formulation (ABSTRACT
161)
Usman Arshad
University of Liverpool, Liverpool, UK
Intrahepatic HDV Activity Is Fueled by Integrated HBV DNA-Derived HBs Independently From cccDNA Size (ABSTRACT
162)
Stefano D'Anna
University of Rome Tor Vergata, Rome, Italy
A 4-Month Regimen of Quabodepistat, Delamanid, and Bedaquiline for Pulmonary TB: Interim Results (ABSTRACT
163)
Simbarashe Takuva
Otsuka Novel Products GmbH
Provisional Results From a 3-month Clofazimine/Rifapentine-Containing Regimen for Drug-Sensitive TB (ABSTRACT
164)
John Metcalfe
University of California, San Francisco
QUESTIONS AND ANSWERS (Part 2)
Association of State-Level PrEP Coverage and State-Level HIV Diagnoses, US, 2012-2021 (ABSTRACT
165)
Patrick S. Sullivan
Emory University, Atlanta, GA, USA
HIV Incidence in Users of HIV Preexposure Prophylaxis in Australia: A Whole-of-Population Analysis (ABSTRACT
166)
Nicholas A. Medland
University of New South Wales, Sydney, Australia
High PrEP Uptake and Adherence Measured Objectively Among Young African Women in the INSIGHT Cohort (ABSTRACT
167)
Brenda G. Mirembe
Makerere University–Johns Hopkins University Research Collaboration, Kampala, Uganda
Safety of Dapivirine Vaginal Ring and Oral PrEP for HIV Prevention in the Second Trimester (ABSTRACT
168)
Felix Mhlanga
University of Zimbabwe College of Health Sciences Clinical Trials Research Centre
QUESTIONS AND ANSWERS (Part 1)
Phone Calls for PrEP Persistence in Kenyan Women in Postabortal Care: A Cluster Randomized Trial (ABSTRACT
169)
Renee Heffron
University of Alabama at Birmingham, Birmingham, AL, USA
Adherence Benchmarks for TFV-DP in DBS and PBMCs for African Women Using FTC/TDF PrEP (ABSTRACT
170)
Kenneth K. Mugwanya
University of Washington, Seattle, WA, USA
HIV Incidence in the INSIGHT Cohort of African Women: Recency Testing and Prospective Follow-Up (ABSTRACT
171)
Irene Mukui
University of Washington, Seattle, WA, USA
Randomized Trial of SEARCH Dynamic Choice HIV Prevention Including Injectable Cabotegravir (CAB-LA) (ABSTRACT
172)
Moses R. Kamya
Makerere University, Kampala, Uganda
QUESTIONS AND ANSWERS (Part 2)
HIV-1 Transcription Start Sites Usage and Its Impact on Unspliced RNA Functions In Vivo (ABSTRACT
139)
Saiful Islam
National Institutes of Health, Frederick, MD, USA
Investigation of the Functional Role of DDX42 in HIV-1 Viral RNA Splicing (ABSTRACT
140)
Xiao Lei
The Rockefeller University, New York, NY, USA
Structural Basis of Translation Inhibition by MERS-CoV Nsp1 Reveals a Conserved Mechanism for β-CoVs (ABSTRACT
141)
Michael Vetick
Yale University, New Haven, CT, USA
“Traitor”-Virus-Guided Discovery of Novel Antiviral Factors (ABSTRACT
142)
Caterina Prelli Bozzo
Ulm University Medical Center, Ulm, Germany
QUESTIONS AND ANSWERS (Part 1)
Immunoregulatory Pathways Predict Mortality More Strongly in People With Versus Without HIV (ABSTRACT
143)
Samuel R. Schnittman
Massachusetts General Hospital, Boston, MA, USA
HIV-1 Soluble gp120 Is Associated With Immune Dysfunction in Individuals on Antiretroviral Therapy (ABSTRACT
144)
Mehdi Benlarbi
Université de Montréal, Montreal, Canada
Rapid Emergence and Adaptive Evolution of SARS-CoV-2 Variants in Advanced HIV Infection (ABSTRACT
145)
Sung Hee Ko
National Institutes of Health
Temperature-Dependent SARS-CoV-2 Spike-ACE2 Interaction Is Associated With Viral Transmission (ABSTRACT
146)
Andrés Finzi
Université de Montréal, Montreal, Canada
|
<< first | < prev
page:
of 2
|
records per page:
next >
| last >>
|
| pages: 1 2
|
presentations:
1 to
50 of
91
|
